Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study.

Authors :: Hill RC
Wang Y
Shaikh B
Ong M
Christos PJ
Lipner SR
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jun; Vol. 90 (6), pp. 1245-1247. Date of Electronic Publication: 2024 Mar 12.
Publication Year :: 2024
Abstract: Competing Interests: Conflicts of interest Ms Hill, Drs Wang and Shaikh, Mr Ong, Drs Christos and Lipner have no conflicts of interest.

Subjects :: Humans
Retrospective Studies
Female
Male
Middle Aged
Aged
Skin Diseases drug therapy
Mineralocorticoid Receptor Antagonists therapeutic use
Mineralocorticoid Receptor Antagonists adverse effects
Adult
Hypotension chemically induced
Spironolactone therapeutic use
Spironolactone adverse effects

Full Text Access

Tools